Ahead of the Q3-2026 earnings release for the $maersk stock - here is a link to our current assessment of shareprice, underlying earnings and actionable thresholds
tsadvisoryaps.substack.com/p…
1/3 🇳🇴 Norsk Hydro ($NHY): Earnings recovery
Higher aluminium prices are driving an earnings recovery. Q3 2026 adjusted EBITDA rose 52% YoY to NOK 9.1bn, although the result fell short of consensus.
The key question: how sustainable is the recovery?
2/3 📊 Valuation
At NOK 67.40, Norsk Hydro trades ~39% below our NOK 109.7 buy threshold. Our DCF fair value is NOK 129.1, implying ~92% upside.
The market appears to be pricing in significant caution despite the earnings recovery.
3/3 🔑 What matters next?
The investment case hinges on aluminium prices. Sustained strength could support earnings and unlock significant upside. A reversal could undermine the recovery.
Our view: BUY, but monitor aluminium prices closely.
#NorskHydro #Aluminium #ValueInvesti
$NHY delivered quarterly results today - on the surface it looks ok, share price is down significantly - I will run the number and share actionable thresholds in my substack as soon as they are done
open.substack.com/pub/tsadvi…
TS Advisory retweeted
Drewry rates keep grinding higher! WC $8,007/FEU, up 250% y/y and at a 12-mo high. EC holding above $10k at $10,166, back up after last week's dip.
The pricing power in container shipping right now is on the TP. $ZIM 🔥🔥🔥
TS Advisory retweeted
Konsensusforventninger til Novo Nordisk 2026 omsætningsvækst er gået fra minus 3 til ca. minus 2 %. Kommer der en ny ændring i guidance den 4/11 og flyttes forventningerne fra 0-minus 6 % med -3 i midtpunktet til 0-minus 3 med minus 1,5 % i midtpunktet? #aktier #dkbiz @NordnetDK
Konsensus, 2026 omsætningsudvikling, Novo Nordisk
Kilde: marketscreener.com/quote/sto…
Hello #FinTwit - could someone please take a look at my substack and endorse it. tsadvisoryaps.substack.com/
TS Advisory retweeted
Coloplast is a strong BUY. At DKK 473.4, it trades 31% below our buy threshold of 683.5.
Mr. Market is heavily penalizing temporary Kerecis noise, missing a major underlying earnings step-up to a TTM EPS of DKK 22.73
Coloplast is a strong BUY. At DKK 473.4, it trades 31% below our buy threshold of 683.5.
Mr. Market is heavily penalizing temporary Kerecis noise, missing a major underlying earnings step-up to a TTM EPS of DKK 22.73
Forgot the $COLO-B hashtag - but seems that does not work $COLOB hmm...
Key model criteria (CAPM):
• Perpetuity growth: 2.76% CAGR
• Volatility: 10% on quarterly EPS
• Beta: 0.45 (5Y Morningstar)
• Required return: 5.74%
Fair value is DKK 763.4 (+61% upside). Read the full deep dive on Substack: tsadvisoryaps.substack.com/p…
[$KO] Real Options derived Entry & Exit thresholds tsadvisoryaps.substack.com/p…














